NVO vs. NVS
Compare and contrast key facts about Novo Nordisk A/S (NVO) and Novartis AG (NVS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NVO or NVS.
Correlation
The correlation between NVO and NVS is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NVO vs. NVS - Performance Comparison
Key characteristics
NVO:
-0.42
NVS:
0.15
NVO:
-0.35
NVS:
0.31
NVO:
0.95
NVS:
1.04
NVO:
-0.35
NVS:
0.12
NVO:
-1.04
NVS:
0.33
NVO:
14.18%
NVS:
7.50%
NVO:
35.57%
NVS:
16.59%
NVO:
-71.30%
NVS:
-41.72%
NVO:
-40.30%
NVS:
-18.61%
Fundamentals
NVO:
$386.42B
NVS:
$197.53B
NVO:
$2.95
NVS:
$5.73
NVO:
29.62
NVS:
17.17
NVO:
1.31
NVS:
2.93
NVO:
$270.58B
NVS:
$49.29B
NVO:
$229.07B
NVS:
$36.69B
NVO:
$135.97B
NVS:
$19.76B
Returns By Period
In the year-to-date period, NVO achieves a -14.61% return, which is significantly lower than NVS's 1.17% return. Over the past 10 years, NVO has outperformed NVS with an annualized return of 17.50%, while NVS has yielded a comparatively lower 6.41% annualized return.
NVO
-14.61%
-17.68%
-38.56%
-14.63%
26.61%
17.50%
NVS
1.17%
-6.18%
-7.58%
2.18%
6.02%
6.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NVO vs. NVS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NVO vs. NVS - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 1.66%, less than NVS's 3.84% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 1.66% | 0.99% | 1.18% | 1.34% | 1.86% | 2.12% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% | 1.72% |
NVS Novartis AG | 3.84% | 3.44% | 3.91% | 4.08% | 3.40% | 2.87% | 3.72% | 3.50% | 4.06% | 3.51% | 3.14% | 3.37% |
Drawdowns
NVO vs. NVS - Drawdown Comparison
The maximum NVO drawdown since its inception was -71.30%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for NVO and NVS. For additional features, visit the drawdowns tool.
Volatility
NVO vs. NVS - Volatility Comparison
Novo Nordisk A/S (NVO) has a higher volatility of 21.10% compared to Novartis AG (NVS) at 4.84%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NVO vs. NVS - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities